EP0316456A4 - Ester-substituted thienotriazolodiazepine compounds and their medicinal use. - Google Patents

Ester-substituted thienotriazolodiazepine compounds and their medicinal use.

Info

Publication number
EP0316456A4
EP0316456A4 EP19880904671 EP88904671A EP0316456A4 EP 0316456 A4 EP0316456 A4 EP 0316456A4 EP 19880904671 EP19880904671 EP 19880904671 EP 88904671 A EP88904671 A EP 88904671A EP 0316456 A4 EP0316456 A4 EP 0316456A4
Authority
EP
European Patent Office
Prior art keywords
same
alkyl
different substituents
compounds
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19880904671
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0316456A1 (en
Inventor
Tetsuya Tahara
Minoru Moriwaki
Masao Abe
Michio Terasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Publication of EP0316456A1 publication Critical patent/EP0316456A1/en
Publication of EP0316456A4 publication Critical patent/EP0316456A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19880904671 1987-06-08 1988-06-06 Ester-substituted thienotriazolodiazepine compounds and their medicinal use. Withdrawn EP0316456A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14284187 1987-06-08
JP142841/87 1987-06-08

Publications (2)

Publication Number Publication Date
EP0316456A1 EP0316456A1 (en) 1989-05-24
EP0316456A4 true EP0316456A4 (en) 1990-05-14

Family

ID=15324858

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880904671 Withdrawn EP0316456A4 (en) 1987-06-08 1988-06-06 Ester-substituted thienotriazolodiazepine compounds and their medicinal use.

Country Status (4)

Country Link
US (1) US5028603A (enrdf_load_stackoverflow)
EP (1) EP0316456A4 (enrdf_load_stackoverflow)
JP (1) JPS6479186A (enrdf_load_stackoverflow)
WO (1) WO1988009792A1 (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US5480881A (en) * 1990-06-01 1996-01-02 Korth; Ruth Treatment of disease with paf-acether antagonists and procedure determining their efficacy
CA1324863C (en) * 1988-01-30 1993-11-30 Minoru Moriwaki Thienotriazolodiazepine compounds and pharmaceutical uses thereof
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors
GB8907257D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-paf and anti-ischemic agents
AT394562B (de) * 1989-03-31 1992-05-11 Scras Verfahren zur herstellung neuer thieno-triazolodiazepine
GB8911030D0 (en) * 1989-05-13 1989-06-28 Scras Hetrazepine derivatives
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
AT394563B (de) * 1990-05-09 1992-05-11 Scras Verfahren zur herstellung von thieno-triazolodiazepinderivaten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
ES2037013T3 (es) * 1986-01-21 1993-06-16 Boehringer Ingelheim Kg Procedimiento para preparar tieno-1,4-diazepinas.
JPH06187623A (ja) * 1992-12-15 1994-07-08 Matsushita Electric Ind Co Ltd 磁気記録再生装置
JPH06222718A (ja) * 1993-01-27 1994-08-12 Sekisui Chem Co Ltd 装飾用粘着シートの貼り付け方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents have been disclosed. *

Also Published As

Publication number Publication date
JPH0555511B2 (enrdf_load_stackoverflow) 1993-08-17
US5028603A (en) 1991-07-02
JPS6479186A (en) 1989-03-24
EP0316456A1 (en) 1989-05-24
WO1988009792A1 (en) 1988-12-15

Similar Documents

Publication Publication Date Title
ATE50987T1 (de) Dihydropyridinderivate, deren herstellung und verwendung.
PT84651B (pt) Processo para a preparacao de indolinas 3,3-dissubstituidas e de composicoes farmaceuticas que as contem
NO950009L (no) Heterocykliske forbindelser som farmasöytika
DE10199003I1 (de) Substituierte Thiazolidinionderivate
KR927003052A (ko) 2-아릴티아졸 유도체 및 그의 약제학적 조성물
IL81483A0 (en) Piperazine derivatives and pharmaceutical compositions containing them
EP0168500A4 (en) PURINE COMBATS, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
EP0316456A4 (en) Ester-substituted thienotriazolodiazepine compounds and their medicinal use.
SE7712630L (sv) Forfarande for framstellning av o-alkylerade hydroxylaminer
FR2669927B1 (fr) Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
AU6158486A (en) Dihydro pyridine derivatives
ATE106868T1 (de) N-((2-oxopyrrolidin-1-yl)acetyl>piperazin- derivate und arzneimittel gegen senile dementia.
DE68927311D1 (de) Buten- oder Propensäure-Derivate
DE69621712D1 (de) Arylpiperidin- und Arylpiperazin-Derivate und sie enthaltende Arzneimittel
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
ATE18667T1 (de) Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.
DE68911006D1 (de) Pharmakologisch-aktive Alkylthiobenzimidazol-Derivate und Verfahren zu deren Herstellung.
DE3873939D1 (de) 2-thiomethyl-substituierte pyridine, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DE3675758D1 (de) 5-aminoalkyl-beta-carbolinderivate, ihre herstellung und verwendung als arzneimittel.
ATE101610T1 (de) Indol-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE2075T1 (de) Oxazolin- und thiazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19890203

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19900514

17Q First examination report despatched

Effective date: 19940301

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19940630